These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 11192471)

  • 21. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
    Xyrem International Study Group
    Sleep Med; 2005 Sep; 6(5):415-21. PubMed ID: 16099718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central nervous system depression after ingestion of RenewTrient.
    Olson KR; Dyer JE; Haller C
    N Engl J Med; 1999 Feb; 340(7):570. PubMed ID: 10026060
    [No Abstract]   [Full Text] [Related]  

  • 23. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Russell IJ; Perkins AT; Michalek JE;
    Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy.
    U.S. Xyrem Multicenter Study Group
    Sleep Med; 2004 Mar; 5(2):119-23. PubMed ID: 15033130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An acutely altered toddler.
    Olives TD; Cole JB
    Pediatr Emerg Care; 2014 Mar; 30(3):203-6. PubMed ID: 24589812
    [No Abstract]   [Full Text] [Related]  

  • 27. The reactivity of gamma-hydroxybutyric acid (GHB) and gamma-butyrolactone (GBL) in alcoholic solutions.
    Hennessy SA; Moane SM; McDermott SD
    J Forensic Sci; 2004 Nov; 49(6):1220-9. PubMed ID: 15568693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of REM sleep behavior disorder with sodium oxybate.
    Shneerson JM
    Clin Neuropharmacol; 2009; 32(3):158-9. PubMed ID: 19483483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.
    Scharf MB; Baumann M; Berkowitz DV
    J Rheumatol; 2003 May; 30(5):1070-4. PubMed ID: 12734908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies.
    Carter LP; Flores LR; Wu H; Chen W; Unzeitig AW; Coop A; France CP
    J Pharmacol Exp Ther; 2003 May; 305(2):668-74. PubMed ID: 12606639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetone-free nail polish remover pads: toxicity in a 9-month old.
    Savage T; Khan A; Loftus BG
    Arch Dis Child; 2007 Apr; 92(4):371. PubMed ID: 17376952
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
    Liechti ME; Kunz I; Greminger P; Speich R; Kupferschmidt H
    Drug Alcohol Depend; 2006 Feb; 81(3):323-6. PubMed ID: 16143455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary supplement or dangerous drug? Two case reports of gamma-butyrolactone toxicity.
    Arneson AH; Goetze J
    J Emerg Nurs; 2000 Oct; 26(5):425-9; quiz 526-7. PubMed ID: 11015059
    [No Abstract]   [Full Text] [Related]  

  • 34. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.
    Ondo WG; Perkins T; Swick T; Hull KL; Jimenez JE; Garris TS; Pardi D
    Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase in sleep-related breathing disturbances after treatment with sodium oxybate in patients with narcolepsy and mild obstructive sleep apnea syndrome: two case reports.
    Seeck-Hirschner M; Baier PC; von Freier A; Aldenhoff J; Göder R
    Sleep Med; 2009 Jan; 10(1):154-5. PubMed ID: 18226949
    [No Abstract]   [Full Text] [Related]  

  • 36. Sudden leg paralysis in a 26-year-old nurse.
    Ulrich S; Müller V; Keel M; Seebach JD
    Swiss Med Wkly; 2005 Apr; 135(13-14):206; author reply 206-7. PubMed ID: 15909238
    [No Abstract]   [Full Text] [Related]  

  • 37. Extractionless GC/MS analysis of gamma-hydroxybutyrate and gamma-butyrolactone with trifluoroacetic anhydride and heptafluoro-1-butanol from aqueous samples.
    Sabucedo AJ; Furton KG
    J Sep Sci; 2004 Jun; 27(9):703-9. PubMed ID: 15387466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restless legs syndrome in narcolepsy: a side effect of sodium oxybate?
    Abril B; Carlander B; Touchon J; Dauvilliers Y
    Sleep Med; 2007 Mar; 8(2):181-3. PubMed ID: 17275405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor.
    Frucht SJ; Houghton WC; Bordelon Y; Greene PE; Louis ED
    Neurology; 2005 Dec; 65(12):1967-9. PubMed ID: 16382538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetone-free nail polish removers: are they safe?
    Brown JJ; Nanayakkara CS
    Clin Toxicol (Phila); 2005; 43(4):297-9. PubMed ID: 16035208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.